Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of PROTAC Linker Plasticity on the Solution Conformations and Dissociation of the Ternary Complex
Dhanushka Weerakoon, Rodrigo J. Carbajo, Leonardo De Maria, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 340-349
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo
Christiane Kofink, Nicole Trainor, Barbara Mair, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 146
Linker-Dependent Folding Rationalizes PROTAC Cell Permeability
Vasanthanathan Poongavanam, Yoseph Atilaw, Stephan Siegel, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13029-13040
Open Access | Times Cited: 76
Characteristic roadmap of linker governs the rational design of PROTACs
Yawen Dong, Tingting Ma, Ting Xu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4266-4295
Open Access | Times Cited: 24
PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 19
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, et al.
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167569-167569
Open Access | Times Cited: 47
Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation
Jake A. Ward, Carles Perez‐Lopez, Cristina Mayor‐Ruiz
ChemBioChem (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 35
Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach
Qiuxia Chen, Chuan Liu, Wei Wang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 1, pp. 25-33
Open Access | Times Cited: 29
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 29
Structural Basis of Conformational Dynamics in the PROTAC‐Induced Protein Degradation
Hongtao Zhao
ChemMedChem (2024) Vol. 19, Iss. 14
Open Access | Times Cited: 9
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation
Shirui Wang, Zhanzhan Feng, Can Qu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9842-9856
Closed Access | Times Cited: 9
Analyzing the Linker Structure of PROTACs throughout the Induction Process: Computational Insights
Yihao Li, Xiaoxuan Zhang, Jiali Xie, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
In silico modeling of targeted protein degradation
Wenxing Lv, Xiaojuan Jia, Bowen Tang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117432-117432
Open Access | Times Cited: 1
Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five
Sven Stegemann, Chris Moreton, Sami Svanbäck, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103344-103344
Open Access | Times Cited: 35
Towards design of drugs and delivery systems with the Martini coarse-grained model
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci, et al.
QRB Discovery (2022) Vol. 3
Open Access | Times Cited: 29
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
Melissa Guardigni, Letizia Pruccoli, Alan Santini, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 1963-1970
Open Access | Times Cited: 19
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
Accelerating PROTACs Discovery Through a Direct‐to‐Biology Platform Enabled by Modular Photoclick Chemistry
Ke‐Nian Yan, Yong‐Qiang Nie, Jiayu Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 7
Development of PROTACs using computational approaches
Jingxuan Ge, Chang-Yu Hsieh, Meijing Fang, et al.
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 7
High‐Throughput Miniaturized Synthesis of PROTAC‐Like Molecules
Ye Tian, Maximilian Seifermann, Liana Bauer, et al.
Small (2024) Vol. 20, Iss. 26
Closed Access | Times Cited: 6
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 6
Reversible Assembly of Proteolysis Targeting Chimeras
Weijun Gui, Sarah F. Giardina, Madeline Balzarini, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 7, pp. 1582-1593
Closed Access | Times Cited: 16
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy
Mingfei Wu, Yiquan Wu, Yuyuan Jin, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13852-13878
Closed Access | Times Cited: 5
Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degrader
Cheng‐Liang Zhu, Xiaomin Luo, Tian Tian, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114459-114459
Closed Access | Times Cited: 19
Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Yang Zhou, Shujing Xu, Nerea López-Carrobles, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 12
Combinatorial Ubiquitination REal-time PROteolysis (CURE-PROs): A Modular Platform for Generating Reversible, Self-Assembling Bifunctional Targeted Degraders
Sarah F. Giardina, Elena Valdambrini, Pradeep K. Singh, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5473-5501
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top